Cambridge Cognition, which acquired Winterlight Labs in 2023, establishes a Scientific Advisory Board comprising experts in cognitive science and clinical trials to guide the integration of emerging trends like blood-based biomarkers and collaborative assessments.

ActiGraph and Cambridge Cognition, leading providers of wearable digital health technologies and CNS assessments, respectively, announced a new strategic partnership to deliver a broad suite of assessments to provide a fully-rounded view of mental and physical capabilities. The companies’ technologies have been used together by top 20 pharma companies in clinical trials already.